Aim:
To explore trends and risk factors associated with S. aureus SSI.
Methods:
We identified risk factors for monomicrobial S. aureus SSI from the Swiss multicentre SSI surveillance system using multivariate logistic regression. Both in-hospital and post-discharge SSIs were identified using standardized definitions.
Findings: Over a 6 year period, we collected data on 229,765 surgical patients, of whom 499 (0.22%) developed monomicrobial S. aureus SSI; 459 (92.0%) and 40 (8.0%) were due to MSSA and MRSA, respectively. There was a significant decrease in rates of MSSA SSI factors were male sex (OR 1.38; 95% CI, 1.14-1.66), higher ASA score (per one-point increment: OR 1.30; 95% CI, 1.13-1.51), re-operation for non-infectious reasons (OR 4.59,
Introduction
Surgical site infections (SSIs) due to Staphylococcus aureus are harmful to the patients and costly for society.
1,2 S. aureus is the most frequently reported micro-organism to cause SSI after clean surgery. 3, 4 Several preventive approaches targeting S. aureus SSI are currently under development, including novel decolonization regimens, vaccines, and antibody approaches, although it remains unclear which patient populations or specific situations may benefit most from these (e.g. preoperatively in cardiac surgery patients). [5] [6] [7] Therefore, studies investigating the profile of patients at high risk of S. aureus SSI are needed.
Recently, Allen and Fowler published a double-blind, placebo-controlled trial of a vaccine to prevent S. aureus SSI after cardiothoracic (CT) surgery. 8 One percent of CT surgery cases were complicated by invasive S. aureus infection, with methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) accounting for 81% and 19% of cases, respectively. Pre-operative S. aureus colonization status, body mass index, diabetes mellitus, and surgery type predicted the risk of S. aureus infection in this cohort. 9 Since 2010, a large network of hospitals in Switzerland has participated in the national SSI surveillance program. 10 The aim of the present observational cohort study was to describe the epidemiology and identify predictors of S. aureus SSI in this large and diverse national population of surgical patients, and validate the findings of previous reports.
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Patients and Methods
This cohort study analysed prospectively collected data within a nationwide SSI surveillance network (www.Swissnoso.ch) in Switzerland from January 2010 to December 2015. A detailed description of how the surveillance system functions was previously reported. 10 Briefly, demographic and clinical data were prospectively collected in each hospital during hospital stays and after discharge. Procedures after an implant-based surgery (cardiac surgery, CBGC, CBGB, laminectomy/disc hernia with an implant, hip and knee arthroplasty) undergo a 30-day and a 1-year follow-up, while cases after non-implant-based surgery (all other types of procedure) undergo a 30-day follow-up only. The network uses standardized definitions, post-discharge surveillance [via telephone call to patients and their general practitioners at 30 days (and one year for surgical procedures with implants)] with 93% compliance and case ascertainment by senior physicians with routine on-site checks to ensure quality of data.
10
Hospitals are free to choose which procedures they consider for surveillance, although the minimum number of procedures is three, and for hospitals that perform colon surgery, this procedure category must be part of the three. In paediatrics, surveillance of appendectomy in patients aged <16 years was mandatory. The program was developed according to the principles of the United States' NNIS system, currently named the National Healthcare Safety Network (NHSN).
11,12
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6 wound contamination class, duration of operation more than T time (T time is the length of time in hours that represents the 75 th percentile of procedures reported), time from admission to operation, emergency operation, and pre-operative antibiotic prophylaxis (latest dose prior to incision, within the 24 hours before incision). Appropriate timing of antibiotic administration was defined when given <1 h prior to incision. The NNIS index was used to stratify risks. 12 We excluded non-S. aureus SSI, as well as polymicrobial S. aureus SSI from the study. The reason for the latter is that vertical preventive measure targeting S. aureus only may not be effective in this case, and risk factors may be falsely attributed to other microorganisms associated with the SSI.
Statistical analysis
Descriptive statistics were performed to determine the cumulative incidence of S. aureus, The model fit was assessed using the Hosmer and Lemeshow goodness-of-fit test. The analysis was conducted using SAS, version 9.4 (SAS Institute Inc., Cary, NC, USA). A p-value of ≤0.05 was considered to be statistically significant. All tests were two-tailed.
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Results
Over the 6-year period, data on 239,584 surgical procedures were collected, and the number of hospitals that participated in the network increased from 81 to 155. A total of 1433 cases were excluded due to missing data, including unknown values for ASA (n=1391), contamination class (n=1), emergency surgery (n=1), duration of surgery (n=40) and age (n=12). Median age of all patients was 56 years (IQR 38-72). As shown in Table I , there were more women (57.3%) than men, likely by including Caesarean section and hysterectomy.
Hip arthroplasty was the most common type of surgery (19.8%), followed by Caesarean section (18.5%), knee arthroplasty (11.8%), and colon surgery (11.1%).
There was a total of 8,875 SSI recorded (cumulative SSI incidence, 3.7%). Of these, 5,395
(60.8%) had a diagnostic test performed to establish the microbiologic aetiology of SSI.
There were 670 infections with S. aureus (cumulative incidence, 0.28%), of which 171 were polymicrobial infections (0.07%), and 499 were monomicrobial (0.22%). S. aureus was implicated in 7.5% of all SSI, and was the only pathogen recovered in 5.6% of SSI cases. The incidence of S. aureus SSI in patients with a microbiological specimen performed was 12.4%:
among them, 8% were MRSA.
A total of 8,205 (3.42%) non-S. aureus SSI were excluded from the descriptive, univariate, and multivariate analyses, in addition to the 171 polymicrobial S. aureus SSI, leaving a final study sample size of 229,765 ( Figure S1 , Supplementary Appendix).
Forty-seven hospitals did not report any S. aureus SSI during the study period; differences in major characteristics between hospitals that did and those that did not report S. aureus SSI are presented in 
SSI were smaller in size, less likely to have an intensive care unit, more likely to be private hospitals, and less likely to perform microbiological cultures. Also, they were more likely to have lower cumulative SSI incidence than hospitals that reported S. aureus SSI. There were no differences in teaching/training status, geographical region, or duration of participation in the surveillance network.
The overall cumulative incidence of S. aureus, MSSA, and MRSA SSI was 2.16, 1.99, and 0.17 cases per 1,000 operations, respectively. The greatest absolute numbers of S. aureus infections were observed after hip arthroplasty (n = 163), followed by knee arthroplasty (n = 79; Table I ). The highest procedure-specific cumulative incidence of S. aureus SSI was found in laminectomy with implant (1.71%), CBGB (0.82%), laminectomy without implant (0.49%), and cardiac surgery (0.47%; Table I ). For MRSA SSI, the largest number of cases was documented for patients undergoing hip arthroplasty (n = 11) and CBGB (n = 7). The highest procedure-specific cumulative incidence of MRSA SSI was found in CBGB (0.09%), cardiac surgery (0.06%), and rectal surgery (0.05%; Table I ).
The proportions of completed follow-up after discharge were very high overall (> 90% In contrast to MRSA (p = 0.70), SSI rates due to S. aureus (p = 0.007) and MSSA (p = 0.007), decreased significantly when trends were evaluated by calendar year ( Figure 1A ). This trend M A N U S C R I P T
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10 persisted when it was assessed for a subset of hospitals that participated for at least 3 years and that data were stratified by years of participation: the decreasing trends in SSI for S.
aureus (p = 0.016) and MSSA (p = 0.017), but not MRSA (p = 0.69) were significant ( Figure   1B ). In this analysis, there were increased S. aureus and MSSA SSI in the sixth year of surveillance, however the number of hospitals (n = 69) and procedures (n = 7271) were smaller, resulting in wide confidence intervals of the estimates.
The overall relative proportions of superficial, deep, and organ/space SSI were 38.6%, 20.7%, and 40.7% for S. aureus and 33.3%, 28.2%, and 38.5% for MRSA, respectively. The time trends for the distribution of SSI are shown in Figure S2 (Supplementary Appendix).
Univariate analyses showed that compared with uninfected controls, patients with monomicrobial S. aureus SSI were older, more likely to be male, had a higher NNIS risk index (contributed mainly by ASA score and longer duration of procedure), were more likely to have additional procedures, re-operation for non-infectious reasons, and were less likely to have an emergency operation, laparoscopy/minimally invasive surgery, and contaminated or dirty wound classes (Table II) . Furthermore, these patients were also more likely to have received antibiotic prophylaxis more than 1 hour before the incision, but this includes patients that received therapeutic antibiotic treatment for an already pre-existing infection (within the last 24 hours before incision). For MRSA SSI, the univariate associations were similar except for emergency operations and additional procedures, and antibiotic prophylaxis timing, for which the associations were not statistically significant. For both S.
aureus and MRSA SSI, there was no effect of pre-operative length of in-hospital stay on SSI risk. Unfortunately, many of the above-mentioned predictive factors are not easily modifiable.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Protective factors include administration of antibiotics within 1 hour prior to incision as recommended by international guidelines, 25 and laparoscopy as described previously for SSIs overall.
13
The finding that the oldest age group is "protected" against S. aureus SSI is intriguing, but is also reflected in the trend of S. aureus infections in Switzerland, 17 and has been demonstrated previously. 27 Another unexpected finding is the fact that "dirtier" wounds (i.e. increases in wound contamination class) were associated with decreased risk of S.
aureus SSI. One the one hand, this is contrary to some evidence; 12,28 on the other hand, contaminated surgical procedures concern mostly abdominal surgery with enteric bacteria as most frequent causes of SSI. Moreover, we excluded polymicrobial SSI containing S.
aureus and the vast majority of procedures that were included in this study are "clean"
procedures, which may have introduced a bias.
The individual burden of S. aureus SSI is high, especially for prosthetic joint infections, but 99.7% of surgical patients will not develop S. aureus SSI; therefore, there is a need to focus on patients at highest risk to justify additional expenses for prevention. Large randomized clinical trials demonstrated the impact of a decolonization strategy to prevent S. aureus SSI. 29, 30 Therefore, the World Health Organization now strongly recommends decolonization of S. aureus carriers prior to prosthetic joint and cardiothoracic surgery. 25 Limitations of this study include the lack of routine microbiologic cultures in a subgroup of infected patients. Different practices in hospitals with regards to culturing frequency may have led to detection bias. However, data were prospectively collected, and the staff that entered them in the network's database in a standardized manner (which includes validity checks) also received training. Furthermore, the network performs data validation, as described elsewhere. 31 Importantly, there was a very high proportion of completed postdischarge follow-up. Therefore, we are confident that the data are of high quality.
Limitations that stem from the use of this routinely collected data are the absence of M A N U S C R I P T information on S. aureus carriage and specific comorbidities (e.g. diabetes, renal insufficiency). Another limitation is the exclusion of a portion of the total data, which we did for two main reasons. Firstly, we excluded observations with missing data, but this is unlikely to have a major effect on the final results due to the very small number. Secondly, we excluded polymicrobial S. aureus SSIs, since a vertical preventive measure targeting S.
aureus only may not be effective in this case, and risk factors may be falsely attributed to other microorganisms associated with the SSI.
In summary, this study provides novel insights on time trends and patterns of S. aureus SSI, and expands on knowledge of risk factors for S. aureus SSI, which can be used to target populations that may benefit from vertical, pathogen-specific prevention interventions.
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